The most frequently altered lncRNAs were DLEU1 and DLEU2, followed by MEG3 and MT1DP, both of which had the alteration frequency >2% in 313 TCGA prostate cancer patients (Figure 1B). The gene discussed is MT1DP; the disease is prostate carcinoma.